A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate, cb1, capable of generating broad immunity against a wide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results